Share this article
Share this article
ResearchAndMarkets.com s offering.
The global nebulizers market is expected to decline from $1.67 billion in 2020 to $1.04 billion in 2021 at a compound annual growth rate (CAGR) of -37.7%.
Nebulizers Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for nebulizers which play a critical role in the treatment of patients with COVID-19.
Major players in the nebulizer devices market are Agilent Technologies, Becton Dickinson and Company, Koninklijke Philips N.V., Omron Corporation, Covidien plc, GE Healthcare Ltd., Allied Healthcare Products, Inc, Briggs Healthcare, PARI Pharma, and GF Health Products, Inc.